Literature DB >> 8772720

Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.

C J Hawkes1, C Wasmeier, M R Christie, J C Hutton.   

Abstract

Antibodies to islet cell proteins detected as 37,000 and 40,000 M(r), tryptic fragments (37- and 40-kDa antigens) are strongly associated with progression to IDDM. The 40-kDa antigen has recently been identified as the tyrosine phosphatase-like protein IA-2 (ICA512) whereas the 37-kDa antigen has been suggested to be a different protein that has structural similarity to IA-2. A protein, phogrin, that has 80% amino acid sequence identity to IA-2 in the cytoplasmic domain, has recently been cloned from an insulinoma cell cDNA library. In this study, we have investigated possible relationships between the 37-kDa antigen and phogrin. Antibodies to phogrin were detected in sera from patients with IDDM, and these antibodies were strongly correlated with the presence of antibodies to the 37-kDa antigen. Trypsin treatment of immunoprecipitated phogrin generated a 37,000 M(r) fragment. Recombinant phogrin was able to block autoantibody binding to the 37-kDa antigen but not to the 40-kDa antigen, and rabbit antibodies raised to different regions of phogrin depleted insulinoma cell extracts specifically of the 37-kDa antigen. These results demonstrate that the 37-kDa antigen in IDDM is indistinguishable from phogrin and show that two distinct tyrosine phosphatase-related proteins are major targets of the autoimmune response in the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772720     DOI: 10.2337/diab.45.9.1187

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion.

Authors:  M Pilon; X R Peng; A M Spence; R H Plasterk; H M Dosch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

3.  Monitoring of exocytosis and endocytosis of insulin secretory granules in the pancreatic beta-cell line MIN6 using pH-sensitive green fluorescent protein (pHluorin) and confocal laser microscopy.

Authors:  Mica Ohara-Imaizumi; Yoko Nakamichi; Toshiaki Tanaka; Hidenori Katsuta; Hitoshi Ishida; Shinya Nagamatsu
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

4.  T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.

Authors:  M C Honeyman; N L Stone; L C Harrison
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

5.  Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM.

Authors:  E C Hatfield; C J Hawkes; M A Payton; M R Christie
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

6.  Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility.

Authors:  Alistair J K Williams; Michelle Somerville; Saba Rokni; Ezio Bonifacio; Liping Yu; George Eisenbarth; Beena Akolkar; Michael Steffes; Polly J Bingley
Journal:  J Immunol Methods       Date:  2009-10-18       Impact factor: 2.303

Review 7.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

8.  Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.

Authors:  Chang-yun Hu; Daniel Rodriguez-Pinto; Wei Du; Anupama Ahuja; Octavian Henegariu; F Susan Wong; Mark J Shlomchik; Li Wen
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.

Authors:  Janet M Wenzlau; Kirstine Juhl; Liping Yu; Ong Moua; Suparna A Sarkar; Peter Gottlieb; Marian Rewers; George S Eisenbarth; Jan Jensen; Howard W Davidson; John C Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.

Authors:  Karen T Elvers; Ivey Geoghegan; Debbie K Shoemark; Vito Lampasona; Polly J Bingley; Alistair J K Williams
Journal:  Diabetes       Date:  2012-09-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.